Symbol="CBAY"
AssetType="Common Stock"
Name="Cymabay Therapeu"
Description="CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering therapies to treat liver and other chronic diseases. The company is headquartered in Newark, California."
CIK="1042074"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3876 BAY CENTER PLACE, HAYWARD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1158457000"
EBITDA="-71037000"
PERatio="None"
PEGRatio="0"
BookValue="1.108"
DividendPerShare="0"
DividendYield="0"
EPS="-1.2"
RevenuePerShareTTM="0.33"
ProfitMargin="-2.603"
OperatingMarginTTM="-2.315"
ReturnOnAssetsTTM="-0.222"
ReturnOnEquityTTM="-0.846"
RevenueTTM="31016000"
GrossProfitTTM="-41635000"
DilutedEPSTTM="-1.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="17.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.76"
EVToRevenue="-"
EVToEBITDA="-3.032"
Beta="0.377"
num_52WeekHigh="14.19"
num_52WeekLow="3.155"
num_50DayMovingAverage="10.85"
num_200DayMovingAverage="8.24"
SharesOutstanding="97513000"
DividendDate="None"
ExDividendDate="None"
symbol="CBAY"
open="11.44"
high="12.03"
low="11.27"
price="11.88"
volume="1203532.00"
latest_trading_day="2023-08-18"
previous_close="11.59"
change="0.29"
change_percent="2.5022%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1735208"
Change_recent_avg="0.01"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="1158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
